European clinical practice guidelines on the use of chemotherapy for advanced oesophageal and gastric cancers: a critical review using the AGREE II and the AGREE-REX instruments
Por:
Santero, M, Meade, AG, Acosta-Dighero, R, Gonzalez, L, Melendi, S, Sola, I, Urrutia, G, Quintana, MJ, Cosp, XB
Publicada:
1 ago 2022
Ahead of Print:
1 mar 2022
Resumen:
Purpose To assess the methodological quality of all relevant and recent European clinical practice guidelines (CPGs) for advanced oesophageal and gastric cancers, and to synthesise their recommendations on the use of chemotherapy. Methods We searched PubMed, EMBASE, guidelines repositories, and other sources from 2010 onwards. We appraised quality using AGREE-II and AGREE-REX. Results 11 CPGs were included (five high, five low, and one moderate quality). Most guidelines showed deficiencies in the domain "applicability", with only three scoring above 60%. Nine did not report having sought the views and preferences of the target population. The lowest scores for AGREE-REX were item Values and Preferences of Target Users (1.6; SD 1.3), and item Values and Preferences of Policy/Decision-Makers (1.8; SD 1.7). The domain Clinical Applicability got the highest score and the domain Implementability got the lowest. Conclusions An urgent area of research is how to develop credible and implementable recommendations on the clinical use of CT for advanced oesophageal and gastric cancer. Systematic review registration: PROSPERO (CRD42021236753).
Filiaciones:
Santero, M:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, C St Antoni Maria Claret 167 Pavello 18, Barcelona 08025, Spain
Univ Autonoma Barcelona, Barcelona, Spain
Meade, AG:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, C St Antoni Maria Claret 167 Pavello 18, Barcelona 08025, Spain
Acosta-Dighero, R:
Univ San Sebastian, Fac Hlth Sci, Sch Physiotherapy, Santiago, Chile
Gonzalez, L:
Hosp Prof Dr Rodolfo Rossi, La Plata, Argentina
Melendi, S:
Hosp Gen Agudos Carlos G Durand, Buenos Aires, DF, Argentina
Sola, I:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, C St Antoni Maria Claret 167 Pavello 18, Barcelona 08025, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Urrutia, G:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, C St Antoni Maria Claret 167 Pavello 18, Barcelona 08025, Spain
Univ Autonoma Barcelona, Barcelona, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Quintana, MJ:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, C St Antoni Maria Claret 167 Pavello 18, Barcelona 08025, Spain
Univ Autonoma Barcelona, Barcelona, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
Cosp, XB:
Biomed Res Inst St Pau IIB St Pau, Iberoamer Cochrane Ctr, C St Antoni Maria Claret 167 Pavello 18, Barcelona 08025, Spain
Univ Autonoma Barcelona, Barcelona, Spain
CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
|